Development action with informed and engaged societies

After nearly 28 years, The Communication Initiative (The CI) Global is entering a new chapter. 

Following a period of transition, the global website has been transferred to the University of the Witwatersrand (Wits) in South Africa, where it will be administered by the Social and Behaviour Change Communication Division. Wits' commitment to social change and justice makes it a trusted steward for The CI's legacy and future. 

On the transfer, co-founder Victoria Martin expressed her pleasure to see this work continue under Wits' leadership, knowing that co-founder Warren Feek (1953–2024) would have felt deep pride in The CI Global's Africa-led direction. 

As Wits, we honour the team and partners who sustained The CI for decades and look forward building from that strong base. This includes co-founders Warren Feek (1953-2024) and Victoria Martin as well as La Iniciativa de Comunicación (CILA), which continues independently at lainiciativadecomunicacion.com with links to The CI Global site. We are also eager to forge new partnerships and entertain new ideas as we consider how best to contribute to social and behaviour change in our rapidly evolving environment.

If you are joining the International Social and Behaviour Change Communication (SBCC) Summit in Panama, please join Wits and CILA on Monday, 22 June, to share your thoughts and suggestion for the relaunch of the Communication Initiative. We will be in Pacifica 5 from 12-1:25 for the Refuel, Reflect, and Renew Lunch Series: The Communication Initiative: celebrating a driving force for Communication for Social Change and the way forward. We will reflect on the legacy of Warren Feek and family in creating the Communication Initiative, consider the contributions of CI over the years and then turn our attention towards the future in this dynamic session. 

If you are unable to join us in Panama, we still want to hear from you. Please contribute your thoughts by following this link: https://redcap.link/CommunicationInitiative2026 or reaching out to ci_surveys@commint.com

You can also follow the QR Code:

 https://redcap.link/CommunicationInitiative2026

Time to read
2 minutes
Read so far

HPV Vaccine Coverage in Australia and Associations with HPV Vaccine Information Exposure among Australian Twitter Users

0 comments
Affiliation

Macquarie University (Dyda, Shah, Surian, Martin, Coiera, Dunn); The University of Sydney (Dey, Leask)

Date
Summary

This study is based on the conviction that localised measures of what Twitter users post as tweets (as well as estimates of the information to which they may be exposed) could improve knowledge and attitudes about human papillomavirus (HPV) vaccines by enabling better targeted health promotion and media messaging. In light of the fact that HPV vaccine coverage in Australia is 80% for females and 76% for males, these researchers examined exposure to HPV vaccine related topics among Australian Twitter users to examine associations with HPV vaccine coverage.

Regional differences in information exposure were estimated from 1,103,448 Australian Twitter users and 655,690 HPV-vaccine-related tweets posted between September 6 2013 and September 12017. To derive measures of potential information exposure, the researchers used a machine learning method to classify all known tweets related to HPV vaccines into topics and described groups of similar topics within 6 themes. They then identified any Australian Twitter users who may have seen those tweets by inferring location from their user profile information, aggregated those data into a set of 25 Australian regions, and constructed multivariable regression models examining how differences in exposure to certain themes was correlated with differences in HPV vaccine coverage across those regions, comparing the results to baseline models constructed using information about levels of employment and education.

Exposure to the individual topics and groups varied over time and region, exhibiting the typical burst-like patterns associated with issues that receive intermittent news media coverage. Australian Twitter users often follow users posting international news and information about HPV vaccines, showing that what happens elsewhere in the world is an important part of the information diet of Australians. Most stories associated with the largest peaks in potential exposure related to news media events, including the release of new data and research about the impact that HPV vaccines are expected to have on cervical cancer in Australia and elsewhere, or debates about the representation and amplification of vocal vaccine critics in the news media.

Specifically, peaks correspond to: (a) Australian research showing cervical cancer risk was reduced; (b) Canadian and Australian research showing cervical cancer risk was reduced; (c) reduction in cervical cancer risk in the United States (US); (d) discussions of coverage rates in Australia and reduction in risk in New Zealand; (e) research showing that one dose may be enough; (f) debates about the representation of HPV vaccines on a US television show hosted by Katie Couric; (g) responses to the reversal of a false balance story written in the Canadian newspaper Toronto Star; and (h) videos and stories of adverse events and harm.

Models using topic exposure measures were more closely correlated with HPV vaccine coverage (female: Pearson's R = 0.75 [0.49 to 0.88]; male: R = 0.76 [0.51 to 0.89]) than models using employment and education as factors (female: 0.39 [-0.02 to 0.68]; male: 0.36 [-0.04 to 0.66]). In Australia, positively-framed news tended to reach more Twitter users overall, but vaccine-critical information made up higher proportions of exposures among Twitter users in low coverage regions, where distorted characterisations of safety research and vaccine-critical blogs were popular.

The researchers suggest that a surveillance system that monitors information exposure via social media may provide a complementary source of information for informing the design of public health communication campaigns and broader communication planning that is low-cost, provides localised information, and is effectively real-time.

Source

Human Vaccines & Immunotherapeutics https://doi.org/10.1080/21645515.2019.1596712